Neurobiology of Aging
Volume 32, Issue 12 , Pages 2299-2307 , December 2011

A lifespan MRI evaluation of ventricular enlargement in normal aging mice

  • Chiao-Chi V. Chen

      Affiliations

    • Institute of Biomedical Sciences, Academic Sinica, Taipei, Taiwan, ROC
    • Functional and Micro-magnetic Resonance Imaging Core Facility, Academic Sinica, Taipei, Taiwan, ROC
    • ,
  • Yu-Ying Tung

      Affiliations

    • Institute of Biomedical Sciences, Academic Sinica, Taipei, Taiwan, ROC
    • Functional and Micro-magnetic Resonance Imaging Core Facility, Academic Sinica, Taipei, Taiwan, ROC
    • ,
  • Chen Chang

      Affiliations

    • Institute of Biomedical Sciences, Academic Sinica, Taipei, Taiwan, ROC
    • Functional and Micro-magnetic Resonance Imaging Core Facility, Academic Sinica, Taipei, Taiwan, ROC
    • Corresponding Author InformationCorresponding author at: N123, Institute of Biomedical Sciences, Academia Sinica, 128 Section 2, Academia Rd. Nankang, Taipei 11529, Taiwan. Tel.: +886 2 27899027; fax: +886 2 27887641.

Received 18 May 2009 ,Revised 11 January 2010 ,Accepted 18 January 2010.

References 

  1. Andersen AH, Zhang Z, Zhang M, Gash DM, Avison MJ. Age-associated changes in rhesus CNS composition identified by MRI. Brain Res. 1999;829:90–98
  2. Arndt S, Cohen G, Alliger RJ, Swayze VW, Andreasen NC. Problems with ratio and proportion measures of imaged cerebral structures. Psychiatry Res. 1991;40:79–89
  3. Bradley KM, Bydder GM, Budge MM, Hajnal JV, White SJ, Ripley BD, et al. Serial brain MRI at 3-6 month intervals as a surrogate marker for Alzheimer's disease. Br. J. Radiol. 2002;75:506–513
  4. de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J. Intern. Med. 2004;256:205–223
  5. de Leon MJ, Mosconi L, Blennow K, DeSanti S, Zinkowski R, Mehta PD, et al. Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Ann. N Y Acad. Sci. 2007;1097:114–145
  6. Delatour B, Guegan M, Volk A, Dhenain M. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging. 2006;27:835–847
  7. Dhenain M, Michot JL, Privat N, Picq JL, Boller F, Duyckaerts C, et al. MRI description of cerebral atrophy in mouse lemur primates. Neurobiol. Aging. 2000;21:81–88
  8. Foundas AL, Zipin D, Browning CA. Age-related changes of the insular cortex and lateral ventricles: conventional MRI volumetric measures. J. Neuroimaging. 1998;8:216–221
  9. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch. Neurol. 2000;57:339–344
  10. Frisoni GB, Delacourte A. Neuroimaging outcomes in clinical trials in Alzheimer's disease. J. Nutr. Health. Aging. 2009;13:209–212
  11. Gonzalez-Lima F, Berndt JD, Valla JE, Games D, Reiman EM. Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. Neuroreport. 2001;12:2375–2379
  12. Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement. 2008;4:38–48
  13. Herbert MR, Ziegler DA, Deutsch CK, O’Brien LM, Lange N, Bakardjiev A, et al. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain. 2003;126:1182–1192
  14. Jack CR, Shiung MM, Gunter JL, O’Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004;62:591–600
  15. Jack CR, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227–1231
  16. Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, et al. Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol. Aging. 2009;30:112–124
  17. Kunstyr I, Leuenberger HG. Gerontological data of C57BL/6J mice. I. Sex differences in survival curves. J. Gerontol. 1975;30:157–162
  18. Luxenberg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology. 1987;37:1135–1140
  19. Maheswaran S, Barjat H, Rueckert D, Bate ST, Howlett DR, Tilling L, et al. Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI. Brain Res. 2009;1270:19–32
  20. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A. Correction for head size in brain-imaging measurements. Psychiatry Res. 1993;50:121–139
  21. Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR Am. J. Neuroradiol. 1999;20:207–211
  22. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain. 2008;131:2443–2454
  23. O’Brien LM, Ziegler DA, Deutsch CK, Kennedy DN, Goldstein JM, Seidman LJ, et al. Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harv. Rev. Psychiatry. 2006;14:141–151
  24. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc. Natl. Acad. Sci. U.S.A. 2003;100:1381–1386
  25. Redzic ZB, Preston JE, Duncan JA, Chodobski A, Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr. Top. Dev. Biol. 2005;71:1–52
  26. Resnick SM, Goldszal AF, Davatzikos C, Golski S, Kraut MA, Metter EJ, et al. One-year age changes in MRI brain volumes in older adults. Cereb. Cortex. 2000;10:464–472
  27. Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, et al. Volumetric MRI and cognitive measures in Alzheimer disease: comparison of markers of progression. J. Neurol. 2008;255:567–574
  28. Scahill RI, Frost C, Jenkins R, Whitwell JL, Rossor MN, Fox NC. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch. Neurol. 2003;60:989–994
  29. Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC. Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology. 2005;65:119–124
  30. von Kienlin M, Kunnecke B, Metzger F, Steiner G, Richards JG, Ozmen L, et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol. Dis. 2005;18:32–39
  31. Walhovd KB, Fjell AM, Reinvang I, Lundervold A, Dale AM, Eilertsen DE, et al. Effects of age on volumes of cortex, white matter and subcortical structures. Neurobiol. Aging. 2005;26:1261–1270
  32. Wang D, Chalk JB, Rose SE, de Zubicaray G, Cowin G, Galloway GJ, et al. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging. Magn. Reson. Imaging. 2002;20:41–48

PII: S0197-4580(10)00043-6

doi: 10.1016/j.neurobiolaging.2010.01.013

Neurobiology of Aging
Volume 32, Issue 12 , Pages 2299-2307 , December 2011

Article Tools

* Image Usage & Resolution